184 related articles for article (PubMed ID: 18774893)
21. Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
Arant CB; Wessel TR; Ridker PM; Olson MB; Reis SE; Delia Johnson B; Sharaf BL; Pauly DF; Handberg E; Zineh I; Sopko G; Kelsey SF; Noel Bairey Merz C; Pepine CJ
Clin Cardiol; 2009 May; 32(5):244-50. PubMed ID: 19452486
[TBL] [Abstract][Full Text] [Related]
22. Electrocardiographic predictors of cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
Triola B; Olson MB; Reis SE; Rautaharju P; Merz CN; Kelsey SF; Shaw LJ; Sharaf BL; Sopko G; Saba S
J Am Coll Cardiol; 2005 Jul; 46(1):51-6. PubMed ID: 15992635
[TBL] [Abstract][Full Text] [Related]
23. Long-term mortality and estimated functional capacity among women with symptoms of ischemic heart disease: From the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
Elgendy IY; Mansoor H; Li Q; Guo Y; Handberg EM; Bairey Merz CN; Pepine CJ
Am Heart J; 2018 Dec; 206():123-126. PubMed ID: 30237012
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Doyle M; Weinberg N; Pohost GM; Bairey Merz CN; Shaw LJ; Sopko G; Fuisz A; Rogers WJ; Walsh EG; Johnson BD; Sharaf BL; Pepine CJ; Mankad S; Reis SE; Vido DA; Rayarao G; Bittner V; Tauxe L; Olson MB; Kelsey SF; Biederman RW
JACC Cardiovasc Imaging; 2010 Oct; 3(10):1030-6. PubMed ID: 20947048
[TBL] [Abstract][Full Text] [Related]
25. Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation.
Barsky L; Merz CNB; Wei J; Shufelt C; Handberg E; Pepine C; Rutledge T; Reis S; Doyle M; Rogers W; Shaw L; Sopko G
Curr Atheroscler Rep; 2020 Jun; 22(8):35. PubMed ID: 32556630
[TBL] [Abstract][Full Text] [Related]
26. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
[TBL] [Abstract][Full Text] [Related]
27. Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
Eastwood JA; Johnson BD; Rutledge T; Bittner V; Whittaker KS; Krantz DS; Cornell CE; Eteiba W; Handberg E; Vido D; Bairey Merz CN
J Womens Health (Larchmt); 2013 Sep; 22(9):724-32. PubMed ID: 23992103
[TBL] [Abstract][Full Text] [Related]
28. Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study.
Bairey Merz CN; Olson MB; Kelsey SF; Bittner V; Reis SE; Reichek N; Handberg E
PLoS One; 2018; 13(12):e0207223. PubMed ID: 30507935
[TBL] [Abstract][Full Text] [Related]
29. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Wei J; Mehta PK; Johnson BD; Samuels B; Kar S; Anderson RD; Azarbal B; Petersen J; Sharaf B; Handberg E; Shufelt C; Kothawade K; Sopko G; Lerman A; Shaw L; Kelsey SF; Pepine CJ; Merz CN
JACC Cardiovasc Interv; 2012 Jun; 5(6):646-53. PubMed ID: 22721660
[TBL] [Abstract][Full Text] [Related]
30. Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: findings from the National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Lewis JF; McGorray S; Lin L; Pepine CJ; Chaitman B; Doyle M; Edmundowicz D; Sharaf BL; Merz CN;
Am Heart J; 2005 Mar; 149(3):527-33. PubMed ID: 15864243
[TBL] [Abstract][Full Text] [Related]
31. Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).
Kenkre TS; Malhotra P; Johnson BD; Handberg EM; Thompson DV; Marroquin OC; Rogers WJ; Pepine CJ; Bairey Merz CN; Kelsey SF
Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):. PubMed ID: 29217675
[TBL] [Abstract][Full Text] [Related]
32. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
Wessel TR; Arant CB; Olson MB; Johnson BD; Reis SE; Sharaf BL; Shaw LJ; Handberg E; Sopko G; Kelsey SF; Pepine CJ; Merz NB
JAMA; 2004 Sep; 292(10):1179-87. PubMed ID: 15353530
[TBL] [Abstract][Full Text] [Related]
33. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE).
Bittner V; Johnson BD; Zineh I; Rogers WJ; Vido D; Marroquin OC; Bairey-Merz CN; Sopko G
Am Heart J; 2009 Mar; 157(3):548-55. PubMed ID: 19249427
[TBL] [Abstract][Full Text] [Related]
34. Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation study.
Whittaker KS; Krantz DS; Rutledge T; Johnson BD; Wawrzyniak AJ; Bittner V; Eastwood JA; Eteiba W; Cornell CE; Pepine CJ; Vido DA; Handberg E; Merz CN
Psychosom Med; 2012 Apr; 74(3):263-70. PubMed ID: 22434916
[TBL] [Abstract][Full Text] [Related]
35. Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).
Mekonnen G; Hayek SS; Mehta PK; Li Q; Mahar E; Mou L; Kenkre TS; Petersen JW; Azarbal B; Samuels B; Anderson RD; Sedlak T; Zaya M; Agarwal M; Haftbaradaran A; Minissian M; Handberg E; Pepine CJ; Cogle CR; Bairey Merz CN; Waller EK; Quyyumi AA
Atherosclerosis; 2016 Oct; 253():111-117. PubMed ID: 27596135
[TBL] [Abstract][Full Text] [Related]
36. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
Kern DM; Mellström C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
Curr Med Res Opin; 2016; 32(4):703-11. PubMed ID: 26709864
[TBL] [Abstract][Full Text] [Related]
37. Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study.
Olson MB; Krantz DS; Kelsey SF; Pepine CJ; Sopko G; Handberg E; Rogers WJ; Gierach GL; McClure CK; Merz CN;
Psychosom Med; 2005; 67(4):546-52. PubMed ID: 16046366
[TBL] [Abstract][Full Text] [Related]
38. TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Petersen JW; Johnson BD; Kip KE; Anderson RD; Handberg EM; Sharaf B; Mehta PK; Kelsey SF; Merz CN; Pepine CJ
PLoS One; 2014; 9(5):e96630. PubMed ID: 24800739
[TBL] [Abstract][Full Text] [Related]
39. Hormone replacement, race, and psychological health in women: a report from the NHLBI-Sponsored WISE Study.
Olson MB; Bairey Merz CN; Shaw LJ; Mankad S; Reis SE; Pohost GM; Smith KM; McGorray SP; Cornell CE; Kelsey SF;
J Womens Health (Larchmt); 2004 Apr; 13(3):325-32. PubMed ID: 15130261
[TBL] [Abstract][Full Text] [Related]
40. Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Mohandas R; Segal M; Srinivas TR; Johnson BD; Wen X; Handberg EM; Petersen JW; Sopko G; Merz CN; Pepine CJ
Am Heart J; 2015 Mar; 169(3):412-8. PubMed ID: 25728732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
